News | EuroPCR | May 05, 2020

EuroPCR Cancels Annual Meeting Due to COVID-19

EuroPCR Cancels Annual Meeting Due to COVID-19. #SARScov2 #COVID19

May 5, 2020 — The large European interventional cardiology conference EuroPCR has been cancelled due to the contenting containment efforts for COVID-19 (SARS-CoV-2).

"The sanitary and legal environment, and in particular the decisions of the French government barring public gatherings for events exceeding 5,000 participants, have resulted in us cancelling the EuroPCR 2020 Course in Paris as a consequence of the COVID-19 outbreak," stated a letter sent out by EuroPCR today from the EuroPCR Course Directors Andreas Baumbach, Alberto Cremonesi, Jean Fajadet and William Wijns.

They said over the last two to three months, the Paris Course on Revascularization (PCR) mission of sharing knowledge, experience and practice has remained more actively relevant than ever with multiple educational resources freely available on PCRonline.

The organizers of the meeting said they will be working with the program committee to provide a full update on late-breaking trials and other essential educational content. Details of the dates and platform to be used will be announced in the coming weeks.

"We reiterate our heartfelt solidarity to all those affected by the coronavirus across the globe and extend our warmest wishes for good health to you and your patients, colleagues and loved ones," the course directors said in the statement. 

For additional information on the status of EuroPCR. 

 

Related Cardiology Conference Cancellations Due to COVID-19:

Cardiology Meetings Continue to be Cancelled or Go Virtual Due to COVID-19

SCCT Plans to Make 2020 Annual Meeting Virtual Due to COVID-19

ACC Cancels 2020 Conference Amid Coronavirus Concerns

Heart Rhythm Society Cancels 2020 Meeting Due to COVID-19

European Heart Rhythm Association Cancelled Due to Coronavirus

 

Related Content

News | Coronavirus (COVID-19)

January 4, 2022 — The Omicron variant, as of Dec. 25, made up 58.6% of new COVID-19 infections in the U.S., according to ...

Home January 04, 2022
Home
News | Coronavirus (COVID-19)

January 3, 2022 — The U.S. Food and Drug Administration (FDA) recently revised its Janssen COVID-19 Vaccine Fact Sheets ...

Home January 03, 2022
Home
News | Coronavirus (COVID-19)

December 23, 2021 — An interdisciplinary research team from the University of Göttingen and Hannover Medical School (MHH ...

Home December 23, 2021
Home
Feature | Coronavirus (COVID-19)

COVID-19 was the single biggest topic readers came to DAIC for information in 2021, resulting in more than 300,000 ...

Home December 16, 2021
Home
News | Coronavirus (COVID-19)

December 15, 2021 — As COVID-19 variants continue to spread and individuals struggle with lingering effects long after ...

Home December 15, 2021
Home
Videos | Coronavirus (COVID-19)

Jean Jeudy, M.D., professor of radiology and vice chair of informatics at the University of Maryland School of Medicine ...

Home December 14, 2021
Home
News | Coronavirus (COVID-19)

December 7, 2021 – Critically ill patients with COVID-19 can safely be transported for lifesaving extracorporeal ...

Home December 07, 2021
Home
Videos | Coronavirus (COVID-19)

Kate Hanneman, M.D., MPH FRCPC, director of cardiac imaging research JDMI, and the medical imaging site director at ...

Home December 06, 2021
Home
News | Coronavirus (COVID-19)

December 1, 2021 — A small but significant percentage of college athletes with COVID-19 develop myocarditis, a ...

Home December 01, 2021
Home
News | Coronavirus (COVID-19)

November 23, 2021 — The antiplatelet drug class of P2Y12 inhibitors that block the activity of platelets and prevents ...

Home November 23, 2021
Home
Subscribe Now